The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.
Patients are ≥12 years and ≤ 60 years of age at the time of surgery.
Symptomatic patient presenting with moderate to severe pain in the index knee - unresponsive to conservative treatment (i.e., medication, bracing, physical therapy) and/or previous surgical intervention OR unsalvageable lesion that requires transplantation at the discretion of the treating physician.
Radiographically diagnosed, by MRI or CT scans, or through arthroscopy, to have a cartilage defect on the femoral condyle between 0.9-8.0 cm2 in size.
Will be having an osteochondral transplant procedure.
Bipolar articular cartilage involvement (kissing lesions) of the ipsilateral compartment (i.e., > than ICRS Grade 2 on the opposing articular surface).
Has had a prior osteochondral allograft transplant procedure in the same knee.
Will be receiving a meniscus allograft transplantation in the same procedure.
Body Mass Index (BMI)of ≥ 35 kg/m2.